|1.||Lü, Junxuan: 12 articles (01/2014 - 10/2002)|
|2.||Dong, Yan: 12 articles (01/2012 - 01/2002)|
|3.||Ip, Clement: 11 articles (09/2010 - 01/2002)|
|4.||Hu, Hongbo: 9 articles (01/2014 - 03/2005)|
|5.||Wang, Lei: 7 articles (01/2014 - 02/2008)|
|6.||Jiang, Cheng: 6 articles (05/2010 - 10/2002)|
|7.||Rowan, Brian G: 5 articles (01/2012 - 08/2005)|
|8.||Cheng, Wen-Hsing: 4 articles (01/2014 - 11/2011)|
|9.||Wang, Zhe: 4 articles (01/2014 - 01/2008)|
|10.||Joel, Simon P: 4 articles (01/2012 - 11/2007)|
|1.||Prostatic Neoplasms (Prostate Cancer)
09/01/2010 - "Previous studies have demonstrated that physiological concentrations of methylseleninic acid (MSA) inhibits the growth of prostate cancer cells. "
09/01/2010 - "Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells."
05/01/2010 - "Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells."
11/01/2007 - "LNCaP human prostate cancer cells were treated with 0.05 mumol/L (control) or 5.0 mumol/L (high) Se as methylseleninic acid (MSA). "
09/01/2005 - "Here, we demonstrate that concomitant administration of TRAIL and methylseleninic acid (MSA) produces synergistic effects on the induction of apoptosis in androgen-dependent LNCaP and androgen-independent DU-145 prostate cancer cells. "
12/01/2015 - "Previous studies reported that the antiproliferative and pro-apoptotic activities of methylseleninic acid (MSA) in cancer cells could be mediated by inhibition of the PI3K pathway. "
06/15/2014 - "Here, we investigated the effect of methaneseleninic acid (MSA; 41 µg/kg) and/or γ-tocopherol (γT; 20.8 mg/kg or 41.7 mg/kg) in Nu/J mice implanted with 22Rν1 tumors. "
04/01/2012 - "Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad."
03/30/2012 - "Methylseleninic acid (MSeA) can activate DNA damage responses and is a superior compound to suppress tumorigenesis in mouse models of cancer. "
01/01/2008 - "Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density."
|3.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer."
01/01/2012 - "Our findings thus provide strong justification for the further development of methylseleninic acid and paclitaxel combination therapy for the treatment of triple-negative breast cancer."
01/01/2012 - "Through combination-index value calculation, we demonstrated that methylseleninic acid synergistically enhanced the growth inhibitory effect of paclitaxel in triple-negative breast cancer cells. "
09/01/2008 - "We showed previously that the organoselenium compound methylseleninic acid (MSA) increased the growth-inhibitory effect of tamoxifen and reversed tamoxifen resistance in breast cancer cells. "
09/01/2008 - "Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells."
|4.||Colonic Neoplasms (Colon Cancer)
12/15/2009 - "Methylseleninic acid (MSA), which is a substrate for TR1, enhanced cytotoxicity to colon cancer cells when TR1 was attenuated. "
01/01/2015 - "The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice."
12/15/2009 - "Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity."
01/01/2015 - "We tested the hypothesis that oral dosing methylseleninic acid (MSeA), a methylselenol precursor, inhibits the growth of colon cancer xenografts in C57BL/6 mice fed a Se adequate diet. "
04/01/2012 - "In the present study, a second-generation selenium compound methylseleninic acid (MSeA) synergistically sensitized MDA-MB-231 human breast cancer cells, HT-29 human colon cancer cells and DU145 human prostate cancer cells to apoptosis induction by ABT-737, as evidenced by greater than additive enhancement of Annexin V/FITC positive (apoptotic) cells and activation of multiple caspases and PARP cleavage. "
05/01/2009 - "Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and methylselenocysteine (MSeC) against prostate carcinogenesis and to characterize potential mechanisms. "
08/01/2010 - "We have recently shown significant preventive benefit of methylseleninic acid (MSeA) and Se-methylselenocysteine (MSeC) in the transgenic adenocarcinoma mouse prostate (TRAMP) model by oral administration. "
10/01/2014 - "This study aimed to evaluate the effects of selenium compounds [methylseleninic acid (MSA) and selenite] on cell proliferation and death, expression of the tumor suppressor gene RASSF1A and epigenetic marks in MCF-7 human breast adenocarcinoma cells. "
|4.||Sodium Selenite (Selenite)
|8.||Proteins (Proteins, Gene)
|1.||Heterologous Transplantation (Xenotransplantation)